Lobbying

Altamed Health Services's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $490K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

Altamed Health Services

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$490K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Altamed Health Services lobbying by quarter
Altamed Health Services lobbying by quarter
QuarterAmountReports
Q4 2022$30K2
Q1 2023$40K2
Q2 2023$40K2
Q3 2023$50K2
Q4 2023$50K2
Q1 2024$50K2
Q2 2024$40K2
Q3 2024$50K2
Q4 2024$40K2
Q1 2025$70K2
Q2 2025$100K3
Q3 2025$170K3
Q4 2025$140K3
Q1 2026$170K3
Q2 2026$180K3
Q3 2026$00

By issue

  • Health issues$840K · 34 reports
  • Medicare and Medicaid$245K · 5 reports
  • Budget and appropriations$135K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES31 reports
  • SENATE30 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Ballard Partners$490K5 quarters
Actum I$450K15 quarters
Leavitt Partners$280K15 quarters

Former officials lobbying for it

Former position
DAVID LEEStaff Assistant - Senate; Legislative Correspondent - SenateQ2 2026
JENNIFER KAUFMANNCounsel/Rules Associate for Hon. Alcee Hastings (D-FL); Legal Intern, House Judiciary Committee; Deputy Scheduler, Sen. Ben Cardin (D-MD)Q2 2026
TRACIE POUGHChief of Staff to U.S. Representative Debbie Wasserman Schultz 2003-2008 & 2009-2025 (Lobbying does not include House Appropriations)Q2 2026
ROBERT CLAYTON ALSPACHChief Health Counsel for Chair - House E&C Committee (E&C); Counsel - E&C; Clerk - E&C; and paid Intern - E&CQ4 2024

Lobbying reports

Filed by
07/17for Q2Actum I$30K
07/15for Q2Leavitt Partners$30K
07/14for Q2Ballard Partners$120K
04/20for Q1Leavitt Partners$20K
04/19for Q1Actum I$30K
04/14for Q1Ballard Partners$120K
01/18for Q4 2025Actum I$30K
01/12for Q4 2025Ballard Partners$90K
01/09for Q4 2025Leavitt Partners$20K
25/10/20for Q3 2025Leavitt Partners$20K
25/10/19for Q3 2025Actum I$30K
25/10/14for Q3 2025Ballard Partners$120K
25/07/20for Q2 2025Actum I$30K
25/07/15for Q2 2025Leavitt Partners$30K
25/07/15for Q2 2025Leavitt Partners$30K
25/07/14for Q2 2025Ballard Partners$40K
25/06/17for Q2 2025Ballard PartnersUnder $5,000
25/04/22for Q1 2025Leavitt Partners$40K
25/04/16for Q1 2025Actum I$30K
25/01/20for Q4 2024Actum I$30K